Is It Time To Reassess Doximity (DOCS) After Its Steep Share Price Slide

Simply Wall St.04-25 05:13

If you are wondering whether Doximity's current share price reflects its true worth, you are not alone. This article breaks down what the latest data says about value. The stock recently closed at US$...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2630785288?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574","is_english":true,"pubTime":"2026-04-25 05:13","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2630785288","market":"nz","top_or_hot":-1,"title":"Is It Time To Reassess Doximity (DOCS) After Its Steep Share Price Slide","media":"Simply Wall St.","content":"<div>\n<p>If you are wondering whether Doximity's current share price reflects its true worth, you are not alone. This article breaks down what the latest data says about value. The stock recently closed at US$...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nyse-docs/doximity/news/is-it-time-to-reassess-doximity-docs-after-its-steep-share-p\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is It Time To Reassess Doximity (DOCS) After Its Steep Share Price Slide</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs It Time To Reassess Doximity (DOCS) After Its Steep Share Price Slide\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-04-25 05:13 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/healthcare/nyse-docs/doximity/news/is-it-time-to-reassess-doximity-docs-after-its-steep-share-p><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>If you are wondering whether Doximity's current share price reflects its true worth, you are not alone. This article breaks down what the latest data says about value. The stock recently closed at US$...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nyse-docs/doximity/news/is-it-time-to-reassess-doximity-docs-after-its-steep-share-p\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"DOCS","symbol_name":"Doximity, Inc.","start_time":0,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-docs/doximity/news/is-it-time-to-reassess-doximity-docs-after-its-steep-share-p","article_id":"2630785288","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-docs/doximity/news/is-it-time-to-reassess-doximity-docs-after-its-steep-share-p","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2630785288","pubTimestamp":1777065202,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"If you are wondering whether Doximity's current share price reflects its true worth, you are not alone. This article breaks down what the latest data says about value.\nThe stock recently closed at US$23.17, with returns of a 4.5% decline over 7 days, a 4.8% decline over 30 days, a 46.5% decline year to date and a 58.8% decline over the past year.\nThese moves have put more attention on how the market is currently pricing Doximity and whether sentiment has shifted too far in one direction...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"DOCS":"Doximity, Inc.","BK4551":"寇图资本持仓","BK4588":"碎股","DCF":"Dreyfus Alcentra Global Credit Income 2024 Target Term Fund, Inc","BK4539":"次新股","BK4585":"ETF&股票定投概念","BK4613":"AI应用软件","BK4167":"医疗保健技术"},"translate_title":"Doximity(DOCS)股价大幅下滑后是时候重新评估其股价了吗","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"DCF":1,"DOCS":1.5},"content_text":"If you are wondering whether Doximity's current share price reflects its true worth, you are not alone. This article breaks down what the latest data says about value. The stock recently closed at US$23.17, with returns of a 4.5% decline over 7 days, a 4.8% decline over 30 days, a 46.5% decline year to date and a 58.8% decline over the past year. These moves have put more attention on how the market is currently pricing Doximity and whether sentiment has shifted too far in one direction. That makes it especially important to look past recent price swings and focus on what different valuation methods indicate about the business. Doximity currently has a value score of 5 out of 6. The sections that follow compare what that means across various valuation approaches before finishing with a more complete way to think about valuation overall.  Find out why Doximity's -58.8% return over the last year is lagging behind its peers. AdvertisementApproach 1: Doximity Discounted Cash Flow (DCF) Analysis A Discounted Cash Flow, or DCF, model estimates what a business could be worth today by projecting its future cash flows and then discounting those amounts back to a present value. It is essentially asking what future cash generated for shareholders is worth in today’s dollars. For Doximity, the model used is a 2 Stage Free Cash Flow to Equity approach based on cash flow projections. The latest twelve month Free Cash Flow is about $306.6 million, and analyst and extrapolated estimates put projected Free Cash Flow at $419.2 million by 2031. Simply Wall St uses analyst inputs for the earlier years and then extends those estimates further out to complete a 10 year path of cash flows. When all those projected cash flows are discounted back, the DCF model arrives at an estimated intrinsic value of about $39.90 per share, compared with the recent share price of $23.17. That difference implies the shares trade at a 41.9% discount to this DCF estimate, which indicates potential upside relative to what the model suggests the business may be worth. Result: UNDERVALUED Our Discounted Cash Flow (DCF) analysis suggests Doximity is undervalued by 41.9%. Track this in your watchlist or portfolio, or discover 54 more high quality undervalued stocks. DOCS Discounted Cash Flow as at Apr 2026 Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for Doximity. Approach 2: Doximity Price vs Earnings For a profitable business, the P/E ratio is a useful way to think about value because it links what you pay per share with the earnings the company is currently generating. Higher growth expectations or lower perceived risk tend to justify a higher P/E, while slower expected growth or higher risk usually point to a lower, more conservative P/E being reasonable. Doximity currently trades on a P/E of 17.88x. This sits below both the Healthcare Services industry average P/E of 28.33x and the broader peer group average of 32.47x, so the market is valuing each dollar of Doximity's earnings at a lower level than many comparables. Simply Wall St's Fair Ratio is a proprietary estimate of what a \"normal\" P/E might look like for Doximity, given factors such as its earnings growth profile, profit margins, industry, market cap and company specific risks. This tailored Fair Ratio of 19.90x is intended to provide a more specific comparison than a simple peer or industry average because it adjusts for these business characteristics rather than assuming all companies deserve similar multiples. Comparing the Fair Ratio of 19.90x with the current P/E of 17.88x indicates that Doximity is trading below this model-based estimate of fair value. Result: UNDERVALUED NYSE:DOCS P/E Ratio as at Apr 2026 P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 17 top founder-led companies. Upgrade Your Decision Making: Choose your Doximity Narrative Earlier it was mentioned that there is an even better way to understand valuation, and on Simply Wall St this shows up as Narratives. You choose a story for Doximity, link that story to a forecast for revenue, earnings and margins, and arrive at a Fair Value that you can easily compare with the current price to decide whether it looks like a buy, a hold or a sell for you. All of this is available inside the Community page that millions of investors use, with the numbers and Fair Value updating automatically when new earnings or news arrive. A bullish Doximity Narrative might look closer to the US$56 or US$55 upper analyst targets, while a more cautious one might sit nearer the US$25 lower end. You then pick the version that best matches how you see the business playing out. Do you think there's more to the story for Doximity? Head over to our Community to see what others are saying! NYSE:DOCS 1-Year Stock Price Chart  This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2630785288","isCrawlerRequest":true}